Isao Matsumoto

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

Hirokazu Taniguchi, Tadaaki Yamada, Rong Wang et al. · Nature Communications · 2019 · 363 citations · Full text

Medicine, Oncology, Pharmacology +17

Crosstalk to Stromal Fibroblasts Induces Resistance of Lung Cancer to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Wei Wang, Qi Li, Tadaaki Yamada et al. · Clinical Cancer Research · 2009 · 298 citations · Full text

Medicine, Oncology, Pharmacology +17

Long Interspersed Nuclear Element 1 Hypomethylation Is a Marker of Poor Prognosis in Stage IA Non–Small Cell Lung Cancer

Kenichiro Saito, Kazuyuki Kawakami, Isao Matsumoto et al. · Clinical Cancer Research · 2010 · 168 citations · Full text

Medicine, Molecular Biology, Oncology +17

Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer

Rong Wang, Tadaaki Yamada, Kenji Kita et al. · Nature Communications · 2020 · 113 citations · Full text

Medicine, Oncology, Pharmacology +16

Peripheral pulmonary adenoid cystic carcinoma with substantial submucosal extension to the proximal bronchus.

Hiromichi Inoue, A Iwashita, Hideaki Kanegae et al. · Thorax · 1991 · 53 citations · Full text

Medicine, Oncology, Surgery +6